Spotlight on…Bé Wieringa Editor of FEBS Letters since 2004 by Walma, Tine
FEBS Letters 582 (2008) 3847–3847Spotlight on. . .
Be´ Wieringa
Editor of FEBS Letters since 2004Be´ Wieringa did his PhD in biochemistry/molecular biology in
Groningen. Then, he went to the University of Zu¨rich for a
postdoc with Charles Weissmann, working on splicing of glo-
bin messenger RNA. ‘‘I was very intrigued, and still am, about
the genetic information cascade as it ﬂows from DNA to RNA
to protein’’, he says. He is currently a full professor and head
of the Department of Cell Biology, at the Radboud University
Nijmegen Medical Centre. Be´ edits papers for FEBS Letters on
molecular cell biology and genetics, focusing on energy metab-
olism, metabolic signalling and trinucleotide repeat diseases.
What does your lab do?
My current research has two main themes, myotonic dystro-
phy (DM), and the role of energy metabolism in actin-based
cell dynamics. Nowadays, these themes appear more related
than we anticipated at the start of our mission. One aim is
to understand the role of products of the gene that is mutated
in DM. Mutant RNA from that gene is toxic and causes splice-
opathy and cell stress. The normal protein product of that
gene, a serine/threonine protein kinase called DMPK, anchors
to the outer membrane of the mitochondria and regulates as-
pects of mitochondrial physiology. Conversely, DMPK is also
involved in the regulation of actomyosin contractility in mus-
cle cells.
In the other main line of research we focus on the signiﬁcance
of phosphotransfer enzymes like creatine kinase and adenylate
kinase, proteins involved in ATP homeostasis and acto-myosin
fuelling. In our lab, we do a broad range of studies, ranging
from molecular interaction studies to animal model studies. I
think the true challenge for cell biologists is to integrate biolog-
ical, chemical and physical methods. We need to have a better
understanding of cellular events in 4D, in time and space. Use
of microscopy imaging of life cells is therefore a must.
What is myotonic dystrophy?
Myotonic dystrophy (DM) is an inheritable muscle disorder,
characterized by abnormal contraction and wasting of mus-
cles, and brain, heart or eye-lens problems. The disease is
caused by expansion of a trinucleotide repeat inserted in the
non-coding region of the DMPK gene. The repeat consists
of multiple CTG.CAG triplets and shows length heterogeneity
across cells in tissues. Short abnormal repeats with few hun-
dred triplets cause rather mild manifestation of DM, patients
with severe and early onset DM have usually repeats with on
average thousands of triplets. In DM families we see intergen-
erational expansion, grandchildren can have thousands of re-
peats, while the grandparents started out with only a few
hundred.0014-5793/$34.00  2008 Federation of European Biochemical Societies. Pu
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search? Brain and muscles contain cell types that sometimes
have to operate at the limit of their capacity. Dealing with
stress, like the stress caused by abnormal RNA–protein aggre-
gates in DM or by cellular energy (ATP) stress is taxing, easily
superceding the pathophysiological threshold. Brain and mus-
cle cells therefore often have problems with homeostatic re-
serve and are the ﬁrst to be aﬀected.
What happens when you knockout proteins of interest?
Surprisingly, often almost nothing. Mice lacking the DMPK
kinase have very mild problems with their muscles and a mild
memory deﬁcit. Mice lacking creatine kinase isoforms or aden-
ylate kinase, ATP supply enzymes, showed profound adapta-
tion but no cell death or severe dysfunction. Muscles in
creatine kinase knockouts for instance, change in appearance,
perform better in endurance tests and lack burst activity. It
looks as if the mouse has changed from a sprinter into a mar-
athon runner [1]. Mice with deﬁciency of brain creatine kinases
have a partially rewired brain, developmental adaptation and
learning, and behavioural problems, but no loss of basal func-
tions. Our work shows that one should always be aware of the
context in which a gene operates. Cells work as highly ﬂexible
networks of interactions in which macromolecules and metab-
olites have their own role. We saw this very clearly in our stud-
ies. The current emphasis of our studies is the dynamic role of
DMPK and ATP and the importance of inhomogeneity in en-
ergy metabolite distribution.
Do you have a favourite paper?
I still very much value the Nature and Cell papers made during
the beginning of my career in Zu¨rich [2,3]. It was a happy per-
iod in my research life, and the research was done by taking
well deﬁned steps, with clear conclusions that helped to unra-
vel the mechanism behind RNA splicing. Furthermore, I con-
sider the 1993 paper on CK knockout mice as one highlight [1].
The ﬁrst author on that paper, Jan van Deursen, has become a
very successful researcher at the Mayo Clinic in Rochester
(USA). Finally, I also had a quite productive period around
the time of the discovery of the DMPK gene [4] and there is
even hope for the future with our ATP [5,6] and DM studies.
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